Metabolomics in various Diseases
Metabolomics is a novel approach that potentials to enable the detection of states of disease, to categories the patients based on biochemical profiles and to monitor disease progression. Metabolomic analysis may also be able to orient the choice of therapy, identify responders and predict toxicity, paving the way to a customized therapy.
- Metabolomics in Neuropsychiatric Disorders: Metabolomics approach has revealed new opportunities in diagnostics of devastating disorders like neuropsychiatric disorders. Metabolomics-based technologies have the prospective to map early biochemical fluctuations in disease and hence provide a prospect to develop predictive biomarkers that can be used as indicators of pathological deviations prior to development of clinical symptoms of neuropsychiatric disorders.
- Metabolomics in Metabolic Disorders: Metabolomics uses in the identification of metabolites not previously associated with metabolic traits highlight the importance and agitations of particular metabolites and advances novel strategies to prevent type 2 diabetes and illustrate biomarkers that can help with early detection, disease progression and therapeutic response. Consequently, the use of metabolomics in this area will continue to grow in basic research science and clinical medical applications.
- Metabolomics in Cardiovascular Diseases: Cardiovascular diseases are the leading causes of death worldwide. There is a need for the development of particular diagnostic techniques, more effective therapeutic procedures as well as drugs, which can decrease the mortality rate in the course of CVDs. Metabolomic technologies may serve as diagnostic and/or prognostic tools that have the potential to significantly alter the management of CVD. Metabolomics can assist in the interpretation of perturbed metabolic processes, and improves our ability to understand the pathology of ischemic heart disease, atherosclerosis, and heart failure.
- Metabolomic studies in Rheumatoid Arthritis: Metabolites from the nucleic acid and oxidative stress pathways are potential biomarkers for rheumatoid arthritis pathology. Metabolite profiles in rheumatoid arthritis plasma are associated to disease activity and treatment response. Metabolomic studies confirm the hypoxic nature of the inflamed synovial joint in rheumatoid arthritis.
- Metabolomic studies in Systemic Lupus Erythematous: Low histidine levels have been identified in the serum of systemic lupus erythematosus (SLE) and RA could explain the increased incidence of cardiovascular disease observed for both rheumatic diseases. Taurine and citrate levels in the SLE urine metabolome have potential utility as biomarkers for SLE nephritis subtype discrimination.
- studies in Ankylosing Spondylitis: Metabolite levels in serum reflect an alteration in the vitamin D3 metabolism in ankylosing spondylitis. Metabolomic studies of patients and controls identified reduced levels of tryptophan in ankylosing spondylitis, probably due to IFN-γ expression in the disease.
- Metabolomic studies in Psoriatic Arthritis: To date, no studies have directly compared psoriatic arthritis and psoriasis metabolomics profiles. The urine metabolome in psoriatic arthritis is correlated with the changes in disease activity induced by anti-TNF treatment.
- Metabolomic studies in Osteoarthritis: The prediction model built from the urine metabolite concentrations correlates significantly with the Kellgren–Lawrence radiographic scores of osteoarthritis severity. The valine/histidine and the xleucine(isoleucine and leucine)/histidine ratios are potential biomarkers of the development of knee osteoarthritis.
- Metabolomic studies in Gouty Arthritis: Uric acid is not a sufficiently informative biomarker of gouty arthritis and additional markers must be identified. Gouty arthritis also expresses the common core of serum metabolites found in other prevalent arthritis. This common set of metabolites could be useful for the development of improved diagnostic systems.
- Metabolomics in Nephrology: The application of metabolomics in nephrology research has expanded from the initial analyses of uraemia to include both cross-sectional and longitudinal studies of earlier stages of kidney disease. Chronic kidney disease, Diabetic nephropathy, Acute kidney injury, Kidney transplantation and End-stage renal disease
- Metabolomics in Neuropsychiatric Disorders
- Metabolomics in Metabolic Disorders
- Metabolomics in Cardiovascular Diseases
- Metabolomic studies in Rheumatoid Arthritis
- Metabolomic studies in Systemic Lupus Erythematous
- Metabolomic studies in Ankylosing Spondylitis
- Metabolomic studies in Psoriatic Arthritis
- Metabolomic studies in Osteoarthritis
- Metabolomic studies in Gouty Arthritis
- Metabolomics in Nephrology
Related Conference of Metabolomics in various Diseases
7th International Conference on Biochemistry and Glyco Science
14th International Conference on Proteomics, Genomics & Bioinformatics
16th International Conference on Structural and Molecular Biology
Metabolomics in various Diseases Conference Speakers
Recommended Sessions
- Analytical Techniques in Metabolomics
- Computational Methodologies
- Mass Spectroscopy (Ms) based Metabolomics
- Metabolic Modelling and Synthetic Biology
- Metabolomic in the field of Paediatric Medicine
- Metabolomics
- Metabolomics Applications
- Metabolomics Approaches
- Metabolomics in detection of Chemotoxicity
- Metabolomics in Discovering Biomarkers
- Metabolomics in Drug Discovery
- Metabolomics in Nutrition Research
- Metabolomics in Pharmaceutics
- Metabolomics in Precision Medicine
- Metabolomics in Systems Biology
- Metabolomics in the field Of Oncology / Cancer Metabolomic
- Metabolomics in various Diseases
- Nmr-based Metabolomics
- Pharmaco-metabolomics
- Plant and Environmental Metabolomics
- Systems Biology
Related Journals
Are you interested in
- Advances in Proteomics and Bioinformatics - Proteomics 2021 (Netherlands)
- Agricultural and Food Chemistry - Glyco Summit 2021 (Hungary)
- Algal Biotechnology - Biotechnology 2021 (Germany)
- Analytical techniques in Metabolomics - Eurometabolomics-2021 (France)
- Animal and Plant Biochemistry - Glyco Summit 2021 (Hungary)
- Animal biotechnology - Biotechnology 2021 (Germany)
- Applications of genomics - Proteomics 2021 (Netherlands)
- Biochemistry - Glyco Summit 2021 (Hungary)
- Biochemistry and Biophysics - Proteomics 2021 (Netherlands)
- Bioeconomy - Biotechnology 2021 (Germany)
- Bioinformatics - Glyco Summit 2021 (Hungary)
- Bioinformatics - Proteomics 2021 (Netherlands)
- Biomass and Bioenergy - Biotechnology 2021 (Germany)
- Bioorganic and Biological Chemistry - Glyco Summit 2021 (Hungary)
- Biotechnology - Biotechnology 2021 (Germany)
- Biotechnology and Bioprocess Engineering - Biotechnology 2021 (Germany)
- Biotechnology Applications - Biotechnology 2021 (Germany)
- Biotechnology Companies & Market Analysis - Biotechnology 2021 (Germany)
- Biotechnology Enterprise and Entrepreneurship - Biotechnology 2021 (Germany)
- Biotechnology Products - Biotechnology 2021 (Germany)
- Cancer genomics - Proteomics 2021 (Netherlands)
- Cancer Metabolomics Approaches - Metabolomics Congress 2021 (Japan)
- Cardiac Proteomics - Proteomics 2021 (Netherlands)
- Cell Signalling - Glyco Summit 2021 (Hungary)
- Cell/Molecular Biotechnology - Biotechnology 2021 (Germany)
- Clinical Biochemistry - Glyco Summit 2021 (Hungary)
- Clinical genomics - Metabolomics Congress 2021 (Japan)
- Clinical Metabolomics - Metabolomics Congress 2021 (Japan)
- Computational Methodologies - Eurometabolomics-2021 (France)
- Computational Molecular Biology - Proteomics 2021 (Netherlands)
- DNA Punctuation - Glyco Summit 2021 (Hungary)
- Environmental Biotechnology - Biotechnology 2021 (Germany)
- Epigenomics and Epigenetics - Metabolomics Congress 2021 (Japan)
- Food and Nutritional Metabolomics - Metabolomics Congress 2021 (Japan)
- Food biotechnology - Biotechnology 2021 (Germany)
- Functional genomics - Proteomics 2021 (Netherlands)
- Genetics and Genetical Engineering - Biotechnology 2021 (Germany)
- Genomics - Proteomics 2021 (Netherlands)
- Genomics - Metabolomics Congress 2021 (Japan)
- Genomics and Proteomics - Glyco Summit 2021 (Hungary)
- Glycan in Diseases and Therapeutics - Glyco Summit 2021 (Hungary)
- Glycan in Drug Discoveries - Glyco Summit 2021 (Hungary)
- Glyco Immunology - Glyco Summit 2021 (Hungary)
- Glycobiology - Glyco Summit 2021 (Hungary)
- Glycobiology in Lipid Science - Glyco Summit 2021 (Hungary)
- Glycochemistry - Glyco Summit 2021 (Hungary)
- Glycoscience - Glyco Summit 2021 (Hungary)
- Marine Biotechnology - Biotechnology 2021 (Germany)
- Mass Spectrometry in Proteome Research - Proteomics 2021 (Netherlands)
- Mass spectroscopy (MS) based metabolomics - Eurometabolomics-2021 (France)
- Medical Biotechnology - Biotechnology 2021 (Germany)
- Metabolic Modelling and Synthetic Biology - Eurometabolomics-2021 (France)
- Metabolomics - Eurometabolomics-2021 (France)
- Metabolomics Applications - Eurometabolomics-2021 (France)
- Metabolomics Approaches - Eurometabolomics-2021 (France)
- Metabolomics in Discovering Biomarkers - Eurometabolomics-2021 (France)
- Metabolomics in Precision Medicine / Personalised medicine - Eurometabolomics-2021 (France)
- Metabolomics in Systems Biology - Eurometabolomics-2021 (France)
- Metabolomics in the field of Oncology / Cancer Metabolomics - Eurometabolomics-2021 (France)
- Metabolomics in various Diseases - Metabolomics Congress 2021 (Japan)
- Microbial/Industrial biotechnology - Biotechnology 2021 (Germany)
- Nano Biochemistry - Glyco Summit 2021 (Hungary)
- Nano Biotechnology - Biotechnology 2021 (Germany)
- NMR-based metabolomics - Eurometabolomics-2021 (France)
- Pharmaceutical Biotechnology - Biotechnology 2021 (Germany)
- Pharmaco-metabolomics - Eurometabolomics-2021 (France)
- Plant and Agriculture Biotechnology - Biotechnology 2021 (Germany)
- Plant and Environmental Metabolomics - Eurometabolomics-2021 (France)
- Plant and Environmental Metabolomics - Metabolomics Congress 2021 (Japan)
- Protein Expression and Analysis - Metabolomics Congress 2021 (Japan)
- Protein Expression and Analysis - Proteomics 2021 (Netherlands)
- Proteoglycan and Sialic acid - Glyco Summit 2021 (Hungary)
- Proteomics - Eurometabolomics-2021 (France)
- Proteomics - Metabolomics Congress 2021 (Japan)
- Proteomics from Discovery to Function - Proteomics 2021 (Netherlands)
- Proteomics In Biomedical Applications - Metabolomics Congress 2021 (Japan)
- Recent Advances in Glycobiology - Glyco Summit 2021 (Hungary)
- Stem Cell Biotechnology - Biotechnology 2021 (Germany)
- Structural Biochemistry - Glyco Summit 2021 (Hungary)
- Structural Bioinformatics - Proteomics 2021 (Netherlands)
- Structural Biology - Proteomics 2021 (Netherlands)
- Structural genomics - Proteomics 2021 (Netherlands)
- Systems and Synthetic Biotechnology - Biotechnology 2021 (Germany)
- Systems Biology - Eurometabolomics-2021 (France)